📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Pyxis Oncology

1.1 - Company Overview

Pyxis Oncology Logo

Pyxis Oncology

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of antibody therapeutics intended to promote the body's immune response to cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Pyxis Oncology

CarThera Logo

CarThera

HQ: France Website
  • Description: Provider of therapeutic ultrasound-based medical devices for treating brain disorders, including SonoCloud, an intracranial implant that uses low-intensity pulsed ultrasound to temporarily open the blood-brain barrier for enhanced delivery of therapeutic agents, and SonoCloud-9, a nine-emitter version to open larger regions; also conducts preclinical and clinical R&D combining SonoCloud with therapeutic agents to treat brain tumors and neurodegenerative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CarThera company profile →
MaxiVAX Logo

MaxiVAX

HQ: Switzerland Website
  • Description: Provider of clinical-stage cancer immunotherapies and cell-encapsulation delivery platforms, including MVX-ONCO-1 for recurrent/metastatic head and neck squamous carcinoma, Encapsulated Cell Technology for sustained, controlled protein delivery (e.g., low-dose anti-CTLA-4 in a colorectal cancer model), and MVX-ONCO-2, a second-generation personalized immunotherapy for advanced solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MaxiVAX company profile →
HistoGeneX Logo

HistoGeneX

HQ: Belgium Website
  • Description: Provider of biomarker technologies for translational and clinical research via CAP, CLIA, and BELAC-accredited laboratories. Offers integrated sample management and logistics, biomarker strategy support, oncology assays; flow cytometry, histopathology, genomics, immunoassays; plus CellEngine cytometry analysis software and Olink PEA protein biomarker quantification.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HistoGeneX company profile →
Northwest Biotherapeutics Logo

Northwest Biotherapeutics

HQ: United States Website
  • Description: Provider of cancer immunotherapy products, focused on developing and commercializing personalized vaccine candidates: DCVax-L for newly diagnosed glioblastoma multiforme (GBM) in a Phase III trial; DCVax-Direct for direct injection into inoperable solid tumors in a Phase I/II trial; and DCVax-Prostate targeting late-stage, hormone-independent prostate cancer using a proprietary PSMA antigen.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Northwest Biotherapeutics company profile →
Naviscan Logo

Naviscan

HQ: United States Website
  • Description: Provider of organ-specific molecular imaging, designing, manufacturing, and distributing high-resolution PET scanners that provide unprecedented visualization of small body parts and can image virtually any body part that fits into the gantry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Naviscan company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Pyxis Oncology

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Pyxis Oncology

2.2 - Growth funds investing in similar companies to Pyxis Oncology

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Pyxis Oncology

4.2 - Public trading comparable groups for Pyxis Oncology

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Pyxis Oncology

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Pyxis Oncology

What does Pyxis Oncology do?

Pyxis Oncology is a provider of antibody therapeutics intended to promote the body's immune response to cancer.

Who are Pyxis Oncology's competitors?

Pyxis Oncology's competitors and similar companies include CarThera, MaxiVAX, HistoGeneX, Northwest Biotherapeutics, and Naviscan.

Where is Pyxis Oncology headquartered?

Pyxis Oncology is headquartered in United States.

How many employees does Pyxis Oncology have?

Pyxis Oncology has 1,000 employees 🔒.

When was Pyxis Oncology founded?

Pyxis Oncology was founded in 2010 🔒.

What sector and industry vertical is Pyxis Oncology in?

Pyxis Oncology is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Pyxis Oncology

Who are the top strategic acquirers in Pyxis Oncology's sector and industry

Top strategic M&A buyers and acquirers in Pyxis Oncology's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Pyxis Oncology?

Top strategic M&A buyers groups and sectors for Pyxis Oncology include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Pyxis Oncology's sector and industry vertical

Which are the top PE firms investing in Pyxis Oncology's sector and industry vertical?

Top PE firms investing in Pyxis Oncology's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Pyxis Oncology's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Pyxis Oncology's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Pyxis Oncology's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Pyxis Oncology include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Pyxis Oncology's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Pyxis Oncology?

The key public trading comparables and valuation benchmarks for Pyxis Oncology include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Pyxis Oncology for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Pyxis Oncology with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Pyxis Oncology's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Pyxis Oncology with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Pyxis Oncology's' sector and industry vertical?

Access recent funding rounds and capital raises in Pyxis Oncology's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Pyxis Oncology